Transcriptional Control of Hepatocanalicular Transporter Gene Expression

Transport processes for larger organic solutes at the canalicular membrane are mainly driven by members of the superfamily of ATP-binding cassette (ABC) transporters. The functions of these transporters range from bile component secretion to xenobiotica and phase II-conjugate export. The transcriptional control of the expression of their respective genes differs, and this may be to guarantee tissue specificity, effective response to stress, or changes in substrate concentrations. Inside the nucleus, the concentration of competing and specifically activated transcription factors determines the transcriptional activation in transporter gene expression. Some transcription factors function as sensors for metabolites (LXR, FXR, CAR, SREBP, PPARs), xenobiotics (PPARs, PXR), oxidative stress (NF-kappa B, AP-1), or DNA damage (p53). Changes in their nuclear concentrations and activity will influence the transcription rates of the respective target genes that contain specific responsive elements in their 5'-promoter/enhancer DNA sequences. Until now little was known about the transcriptional control of most ABC transporter proteins. However, due to the enormous progress in molecular biology, many tools have become recently available to study and understand the "battle inside the nucleus" with respect to hepatic transporter gene expression.

[1]  J. Boyer,et al.  Molecular pathogenesis of cholestasis. , 2012, The New England journal of medicine.

[2]  R. Stravitz,et al.  Regulation of mdr2 p-glycoprotein expression by bile salts and cholesterol in rats and primary cultures of rat hepatocytes. , 2000 .

[3]  D. Mangelsdorf,et al.  Interleukin-1β Suppresses Retinoid Transactivation of Two Hepatic Transporter Genes Involved in Bile Formation* , 2000, The Journal of Biological Chemistry.

[4]  J. Lehmann,et al.  Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. , 2000, Molecular cell.

[5]  P. Meier,et al.  Transport function and hepatocellular localization of mrp6 in rat liver. , 2000, Molecular pharmacology.

[6]  S. Khorasanizadeh,et al.  Structure of the RXR–RAR DNA‐binding complex on the retinoic acid response element DR1 , 2000, The EMBO journal.

[7]  D. Keppler,et al.  Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. , 2000, European journal of biochemistry.

[8]  H. Takikawa,et al.  ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)* , 2000, The Journal of Biological Chemistry.

[9]  K. Scotto,et al.  Transcriptional Activation of the MDR1 Gene by UV Irradiation , 2000, The Journal of Biological Chemistry.

[10]  F. Thévenod,et al.  Up-regulation of Multidrug Resistance P-glycoprotein via Nuclear Factor-κB Activation Protects Kidney Proximal Tubule Cells from Cadmium- and Reactive Oxygen Species-induced Apoptosis* , 2000, The Journal of Biological Chemistry.

[11]  G. Schmitz,et al.  ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Green,et al.  Molecular cloning and characterization of the murine bile salt export pump. , 2000, Gene.

[13]  M. Luciani,et al.  The ABCA subclass of mammalian transporters. , 1999, Biochimica et biophysica acta.

[14]  D. Keppler,et al.  Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. , 1999, Biochimica et biophysica acta.

[15]  B. Sarkadi,et al.  An inventory of the human ABC proteins. , 1999, Biochimica et biophysica acta.

[16]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions. , 1999, Current opinion in biotechnology.

[17]  H. Takano,et al.  The human multidrug resistance protein 2 gene: Functional characterization of the 5′‐flanking region and expression in hepatic cells , 1999, Hepatology.

[18]  D. Mangelsdorf,et al.  Nuclear receptor regulation of cholesterol and bile acid metabolism. , 1999, Current opinion in biotechnology.

[19]  P. Meier,et al.  Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. , 1999, Gastroenterology.

[20]  A. Wolffe,et al.  Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. , 1999, Journal of molecular endocrinology.

[21]  M. Karin.  How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.

[22]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[23]  W. Wahli,et al.  Steroid and nuclear receptors Villefranche‐sur‐Mer, France, May 25–27, 1999 , 1999, The EMBO journal.

[24]  K. Griffin,et al.  Molecular mechanisms of cytochrome P-450 induction by xenobiotics: An expanded role for nuclear hormone receptors. , 1999, Molecular pharmacology.

[25]  O. Fardel,et al.  Up‐regulation of multidrug resistance‐associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone , 1999, FEBS letters.

[26]  P. Farnham,et al.  Context-dependent Transcriptional Regulation* , 1999, The Journal of Biological Chemistry.

[27]  V. Giguère,et al.  Orphan nuclear receptors: from gene to function. , 1999 .

[28]  D. Meijer,et al.  Induction of hepatic mdr2 expression by cholesterol synthesis inhibitors (statins) is mediated via SERBPs , 1999 .

[29]  M. Manns,et al.  TNF-alpha mediated up-regulation of the multidrug resistance gene mdr1b but not of mrp1 in rat hepatocytes is dependent on NF-kappa B activation , 1999 .

[30]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[31]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Hsiu-Hsiang Lee,et al.  NF‐κB‐dependent Fas ligand expression , 1999 .

[33]  D. Waxman,et al.  P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. , 1999, Archives of biochemistry and biophysics.

[34]  T. Kawamoto,et al.  Phenobarbital-Responsive Nuclear Translocation of the Receptor CAR in Induction of the CYP2B Gene , 1999, Molecular and Cellular Biology.

[35]  G. Hooiveld,et al.  3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats. , 1999, Gastroenterology.

[36]  J. Vamecq,et al.  Medical significance of peroxisome proliferator-activated receptors , 1999, The Lancet.

[37]  J. Boyer,et al.  Molecular regulation of hepatocellular transport systems in cholestasis. , 1999, Journal of hepatology.

[38]  H. Pahl.  Signal transduction from the endoplasmic reticulum to the cell nucleus. , 1999, Physiological reviews.

[39]  E. Zandi,et al.  Bridging the Gap: Composition, Regulation, and Physiological Function of the IκB Kinase Complex , 1999, Molecular and Cellular Biology.

[40]  Michael Karin,et al.  Is NF‐κB the sensor of oxidative stress? , 1999 .

[41]  P. Jansen,et al.  Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats , 2018 .

[42]  S. Cogoi,et al.  Enhancement of mdr2 gene transcription mediates the biliary transfer of phosphatidylcholine supplied by an increased biosynthesis in the pravastatin‐treated rat , 1999, Hepatology.

[43]  D. Russell,et al.  Nuclear Orphan Receptors Control Cholesterol Catabolism , 1999, Cell.

[44]  J A Gustafsson,et al.  Seeking Ligands for Lonely Orphan Receptors , 1999, Science.

[45]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[46]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[47]  D. Keppler,et al.  Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.

[48]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[49]  G. Hooiveld,et al.  Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein. , 1999, Journal of cell science.

[50]  M. Kavallaris,et al.  Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells , 1999, Oncogene.

[51]  K. Umesono,et al.  A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.

[52]  D. Keppler,et al.  Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane , 1999, Hepatology.

[53]  Paavo Honkakoski,et al.  The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene* , 1999, The Journal of Biological Chemistry.

[54]  L. Owen-Schaub,et al.  Activation-Dependent Transcriptional Regulation of the Human fas Promoter Requires NF-κB p50-p65 Recruitment , 1999, Molecular and Cellular Biology.

[55]  V. Sukhatme,et al.  Sp1 and Egr-1 Have Opposing Effects on the Regulation of the RatPgp2/mdr1b Gene* , 1999, The Journal of Biological Chemistry.

[56]  D. Roden,et al.  Human MRP3 transporter: identification of the 5'-flanking region, genomic organization and alternative splice variants. , 1999, Biochimica et biophysica acta.

[57]  S. Kliewer,et al.  Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Q. Wang,et al.  Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. , 1998, Cancer research.

[59]  G. Hooiveld,et al.  Up‐regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down‐regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver , 1998, Hepatology.

[60]  R. Tukey,et al.  Physiological and pathophysiological regulation of cytochrome P450. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[61]  T. Ishikawa,et al.  Expression of Multidrug Resistance Protein/GS-X Pump and γ-Glutamylcysteine Synthetase Genes Is Regulated by Oxidative Stress* , 1998, The Journal of Biological Chemistry.

[62]  S. Cole,et al.  Multidrug resistance mediated by the ATP‐binding cassette transporter protein MRP , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[63]  J. Chiang,et al.  Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors. , 1998, Journal of lipid research.

[64]  Richard J. Thompson,et al.  A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis , 1998, Nature Genetics.

[65]  R. Evans,et al.  Orphan nuclear receptors--new ligands and new possibilities. , 1998, Genes & development.

[66]  W. Sabbagh,et al.  SXR, a novel steroid and xenobiotic-sensing nuclear receptor. , 1998, Genes & development.

[67]  David D. Moore,et al.  Androstane metabolites bind to and deactivate the nuclear receptor CAR-β , 1998, Nature.

[68]  T. Osborne,et al.  Polyunsaturated Fatty Acids Decrease Expression of Promoters with Sterol Regulatory Elements by Decreasing Levels of Mature Sterol Regulatory Element-binding Protein* , 1998, The Journal of Biological Chemistry.

[69]  T. Sueyoshi,et al.  The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene , 1998, Molecular and Cellular Biology.

[70]  D. Peet,et al.  The LXRs: a new class of oxysterol receptors. , 1998, Current opinion in genetics & development.

[71]  J. Lehmann,et al.  The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.

[72]  M. Manns,et al.  I. TNF-induced liver injury. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[73]  Y. Sugiyama,et al.  cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .

[74]  Ge Zhou,et al.  Wild-type p53-mediated Induction of Rat mdr1bExpression by the Anticancer Drug Daunorubicin* , 1998, The Journal of Biological Chemistry.

[75]  Y. Sugiyama,et al.  Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. , 1998, Molecular pharmacology.

[76]  R. Hammer,et al.  Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα , 1998, Cell.

[77]  J. Boyer,et al.  Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. , 1998, The Journal of clinical investigation.

[78]  P. Meier,et al.  The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver* , 1998, The Journal of Biological Chemistry.

[79]  D. Schrenk,et al.  Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. , 1998, Biochemical and biophysical research communications.

[80]  K. Kohno,et al.  Direct Involvement of the Y-box Binding Protein YB-1 in Genotoxic Stress-induced Activation of the Human Multidrug Resistance 1 Gene* , 1998, The Journal of Biological Chemistry.

[81]  T. Ishikawa,et al.  Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues. , 1998, Biochemical pharmacology.

[82]  J. Cidlowski,et al.  Cell cycle regulation and apoptosis. , 1998, Annual review of physiology.

[83]  J. Lehmann,et al.  An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.

[84]  M L Agarwal,et al.  The p53 Network* , 1998, The Journal of Biological Chemistry.

[85]  D. Keppler,et al.  Induction of cMrp/cMoat gene expression by cisplatin, 2‐ acetylaminofluorene, or cycloheximide in rat hepatocytes , 1997, Hepatology.

[86]  E. Schuetz,et al.  p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[87]  D. Moore,et al.  Differential Transactivation by Two Isoforms of the Orphan Nuclear Hormone Receptor CAR* , 1997, The Journal of Biological Chemistry.

[88]  D. Keppler,et al.  The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. , 1997, Gastroenterology.

[89]  V. Vollrath,et al.  Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver. , 1997, Journal of hepatology.

[90]  Ge Zhou,et al.  NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells* , 1997, The Journal of Biological Chemistry.

[91]  C. White,et al.  Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C. , 1997, The Journal of biological chemistry.

[92]  M. Müller,et al.  Molecular aspects of hepatobiliary transport. , 1997, The American journal of physiology.

[93]  L. O’Neill,et al.  Daunorubicin Activates NFκB and Induces κB-dependent Gene Expression in HL-60 Promyelocytic and Jurkat T Lymphoma Cells* , 1997, The Journal of Biological Chemistry.

[94]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[95]  P. Borst,et al.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[96]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[97]  D. Mangelsdorf,et al.  An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.

[98]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[99]  M. Tanimoto,et al.  Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. , 1996, Cancer research.

[100]  J. Silverman,et al.  Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1. , 1996, Nucleic acids research.

[101]  M. Müller,et al.  Secretion of Organic Anions by Hepatocytes: Involvement of Homologues of the Multidrug Resistance Protein , 1996, Seminars in liver disease.

[102]  M. Relling,et al.  P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[103]  J. Capone,et al.  The Orphan Nuclear Hormone Receptor LXR Interacts with the Peroxisome Proliferator-activated Receptor and Inhibits Peroxisome Proliferator Signaling (*) , 1996, The Journal of Biological Chemistry.

[104]  A. Rigotti,et al.  Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. , 1996, The Biochemical journal.

[105]  Q. Zhu,et al.  Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene. , 1996, DNA and cell biology.

[106]  S. Cohn,et al.  Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. , 1996, The New England journal of medicine.

[107]  P. Edwards,et al.  Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[108]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[109]  A. Groen,et al.  Regulation of mdr2 P-glycoprotein expression by bile salts. , 1995, The Biochemical journal.

[110]  D. Meijer,et al.  Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. , 1995, Biochimica et biophysica acta.

[111]  B. A. Hill,et al.  Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter , 1995, Molecular carcinogenesis.

[112]  P. Borst,et al.  Characterization of the promoter region of the human MDR3 P-glycoprotein gene. , 1995, Biochimica et biophysica acta.

[113]  Q. Zhu,et al.  Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. , 1994, Cancer research.

[114]  H. Wu,et al.  NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. , 1994, The Journal of biological chemistry.

[115]  J. Chiang,et al.  Identification and characterization of a putative bile acid-responsive element in cholesterol 7 alpha-hydroxylase gene promoter. , 1994, The Journal of biological chemistry.

[116]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[117]  R. Costa,et al.  The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix , 1994, Molecular and cellular biology.

[118]  D. Moore,et al.  A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements , 1994, Molecular and cellular biology.

[119]  S. Thorgeirsson,et al.  Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication , 1993, Hepatology.

[120]  S. Thorgeirsson,et al.  Cloning and regulation of the rat mdr2 gene. , 1993, Nucleic acids research.

[121]  T. Ishikawa,et al.  The ATP-dependent glutathione S-conjugate export pump. , 1992, Trends in biochemical sciences.

[122]  L. Moore,et al.  The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution , 2000 .

[123]  J. Boyer,et al.  Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. , 2000, Gastroenterology.

[124]  J. Chiang,et al.  HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). , 2000, Journal of lipid research.

[125]  G. Schroepfer,et al.  Oxysterols: modulators of cholesterol metabolism and other processes. , 2000, Physiological reviews.

[126]  B. O’Malley.  Hormones and Signaling , 2000 .

[127]  M. Relling,et al.  Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes. , 2000, Molecular pharmacology.

[128]  R. Kim,et al.  Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. , 2000, Molecular pharmacology.

[129]  M. Kool,et al.  Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. , 1999, Cancer research.

[130]  M. Lutter,et al.  Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.

[131]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[132]  P. Edwards,et al.  Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. , 1999, Annual review of biochemistry.

[133]  M. Mowat,et al.  p53 in tumor progression: life, death, and everything. , 1998, Advances in cancer research.

[134]  D. Mangelsdorf,et al.  Nuclear Orphan Receptors: The Search for Novel Ligands and Signaling Pathways , 1998 .

[135]  Silverman Ja,et al.  Regulation and function of the multidrug resistance genes in liver. , 1995 .

[136]  I. Verma,et al.  Rel/NF-kappa B/I kappa B story. , 1995, Advances in cancer research.